Cooperative Agreement To Support the Western Center for Food Safety, 37228-37230 [2013-14673]
Download as PDF
<![CDATA[
37228
Federal Register / Vol. 78, No. 119 / Thursday, June 20, 2013 / Notices
Grantee organization
City
Children’s Hospital Los Angeles ............................................................
Cicatelli Associates Inc ..........................................................................
Demoiselle 2 Femme .............................................................................
Education Development Center, Inc ......................................................
Lighthouse Outreach ..............................................................................
OhioHealth ..............................................................................................
Oklahoma Institute for Child Advocacy ..................................................
The Village for Families & Children, Inc ................................................
Los Angeles .....................................................
New York .........................................................
Chicago ............................................................
Newton .............................................................
Hampton ...........................................................
Columbus .........................................................
Oklahoma City .................................................
Hartford ............................................................
The period of support under
these supplements is September 30,
2012, through September 29, 2013.
FOR FURTHER INFORMATION CONTACT:
Marc Clark, Program Director,
Adolescent Pregnancy Prevention
Program, Division of Adolescent
Development and Support, Family and
Youth Services Bureau, 1250 Maryland
Avenue SW., Suite 800, Washington, DC
20024. Telephone: 202–205–8496;
Email: marc.clark@acf.hh.gov.
SUPPLEMENTARY INFORMATION: The award
of eight single source expansion
supplement grants to PREIS grantees is
required because of the necessary
expansion of the original scope of
approved activities. In reviewing
grantees’ aggressive program and
evaluation plans, combined with
recruitment efforts to date, FYSB has
determined that that these eight grantees
would be required to increase the
number of program participants and/or
increase data collection efforts.
Increased funding will help the
grantees’ programs increase recruitment
and retention strategies for program
participants that will allow grantees to
obtain the minimal statistical power
required to report significant outcome
data. Outcome data will determine the
effectiveness of the implemented
pregnancy prevention models used in
the program. Thus, the increased
number of program participants
supports the evaluation requirements
outlined in the FOA and the Affordable
Care Act.
Additionally, grantees are required to
report on performance measures that
were specifically defined by FYSB. The
data collection will require additional
grantee staff time and other resources to
compile and report on performance
indicators. Performance indicators are
based upon the performance measures
established by the Department of Health
and Human Services (HHS) to include:
(a) The number of youth served and
hours of service delivery; (b) fidelity to
the program model or adaptation of the
program model for the target
population; (c) community partnerships
and competence in working with the
target population; and (d) reported gains
TKELLEY on DSK3SPTVN1PROD with NOTICES
DATES:
VerDate Mar<15>2010
17:01 Jun 19, 2013
Jkt 229001
in knowledge and intentions, and
changes in self-reported behaviors of
participants.
Award amounts for the eight single
source expansion supplement grants
total $496,875 and will support
activities from September 30, 2012,
through September 29, 2013.
Statutory Authority: Section 2953 of the
Patient Protection and Affordable Care Act of
2010, Public. Law 111–148, added Section
513 to Title V of the Social Security Act,
codified at 42 U.S.C. 713, authorizing the
Personal Responsibility Education Program.
Bryan Samuels,
Commissioner, Administration on Children,
Youth and Families.
[FR Doc. 2013–14741 Filed 6–19–13; 8:45 am]
BILLING CODE 4184–37–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2013–N–0010]
Cooperative Agreement To Support the
Western Center for Food Safety
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing the
availability of grant funds for a
cooperative agreement to support the
Western Center for Food Safety (WCFS).
FDA regards the continued support of
WCFS as crucial to receiving invaluable
insight into the food safety issues that
it is directed to address through various
provisions of the FDA Food Safety
Modernization Act (FSMA). FDA
concludes this partnership will enhance
FDA’s efforts to address the particularly
complex issues surrounding the safety
of agricultural production. Partnering
with WCFS provides FDA with the
opportunity to stimulate collaborations
so that resources can be leveraged to
maximize food safety research,
education, and outreach efforts aimed at
WCFS and FDA stakeholders
particularly those within the
SUMMARY:
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
State
Supplement
award amount
CA
NY
IL
MA
VA
OH
OK
CT
$52,538.00
130,506.00
34,981.00
51,181.00
50,000.00
9,660.00
108,009.00
60,000.00
agricultural community. A key outcome
of this effort is to enhance FDA’s
implementation of the prevention
oriented activities outlined in FSMA.
DATES: Important dates are as follows:
1. The application due date is July 15,
2013.
2. The anticipated start date is
September, 2013.
3. The opening date is June 20, 2013.
4. The expiration date is July 16,
2013.
Submit the paper
application to: Gladys Melendez, Grants
Management (HFA–500), 5630 Fishers
Lane, Rockville, MD 20857, and a copy
to Kevin W. Robinson, Center for Food
Safety and Applied Nutrition, 5100
Paint Branch Pkwy., College Park, MD
20740, 240–402–2118. For more
information, see section III of the
SUPPLEMENTARY INFORMATION section of
this notice.
FOR FURTHER INFORMATION CONTACT:
Samir K. Assar, Center for Food Safety
and Applied Nutrition, Food and Drug
Administration, CPK1 Rm. 3A001, 5100
Paint Branch Pkwy., College Park, MD
20740, 240–402–1636; or Gladys
Melendez, Grants Management Officer/
Specialist, Office of Acquisition and
Grants Services, Food and Drug
Administration, 5630 Fishers Lane, Rm.
2032, Rockville, MD 20857, 301–827–
7175.
For more information on this funding
opportunity announcement (FOA) and
to obtain detailed requirements, please
refer to the full FOA located at
www.fda.gov/food/newsevents/
default.htm.
ADDRESSES:
SUPPLEMENTARY INFORMATION:
I. Funding Opportunity Description
RFA–FD–13–023.
93.103.
A. Background
FDA is announcing its intention to
receive and consider a single-source
application for the award of a
cooperative agreement in fiscal year
2013 (FY13) to the University of
California-Davis, Davis, CA, to support
WCFS.
E:\FR\FM\20JNN1.SGM
20JNN1
TKELLEY on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 78, No. 119 / Thursday, June 20, 2013 / Notices
The partnership between WCFS and
FDA over the past 5 years has been very
productive in supporting FDA’s public
health mission by conducting studies
that address knowledge gaps
surrounding the safe production of
agricultural foods and education/
outreach activities that provide the
agricultural sector with information
about food safety best practices. With
the enactment of FSMA in 2011, the
partnership has become increasingly
important as FDA works to fulfill its
mandate to develop a prevention-based
modern food safety system. FSMA
directs the Agency to develop and
implement risk and science-based
enforceable standards and enhance
partnerships with its food safety
stakeholders. The Agency’s research
strategy is focused on building the
scientific foundation it needs to support
the development and implementation of
science-based standards. The strategy
involves identifying and prioritizing its
research needs based on its
policymaking and implementation
activities. WCFS has played a critical
role in conducting studies that were
used to inform policy, including
regulations that are being developed
under FSMA, and will continue to do so
as the Agency further implements
FSMA activities.
FDA regards the development and
strengthening of public-private
partnerships to be a key element of its
FSMA implementation strategy, which
involves providing education and
outreach to private industry about its
food safety standards in order to build
industry capacity to comply with these
standards prior to conducting
enforcement activities. The Agency has
a limited history with the agricultural
community and seeks to use the strong
relationships that academia has with
this sector to facilitate education and
outreach activities. The demonstrated
ability of WCFS to successfully leverage
resources through existing partnerships
will continue to maximize the ability to
achieve research, education, and
outreach objectives domestically and
internationally with available funds.
The Agency is developing a technical
assistance network that will be critical
in providing technical assistance to the
farming community in adopting and
complying with components of FSMA.
WCFS is optimally situated to be a key
player in this network to deliver quality
technical assistance to a broad range of
food safety stakeholders in the
agricultural community.
B. Research Objectives
This cooperative agreement will
provide continued support so that
VerDate Mar<15>2010
17:01 Jun 19, 2013
Jkt 229001
WCFS can meet the following research
objectives:
• Continue to conduct
multidisciplinary applied laboratory,
field, and educational research
regarding the safety of agriculture
production to generate practical
solutions that can be implemented by
the agricultural community and
consequently, enhance food safety and
food defense for FDA-regulated
products.
• Continue to develop and maintain
communication with various
stakeholders, domestic and
international, involved in food
production and food safety in order to
identify food safety knowledge gaps and
opportunities to leverage resources.
• Continue to enhance technical
assistance outreach and educational
efforts through various channels,
including seminars, presentations,
serving on technical advisory boards
and committees, and outreach through
agriculture extension appointments.
• Continue to engage in multiinstitutional collaborations to ensure
that FDA has the most current scientific
thinking on best agricultural practices
across varying agro-ecological
landscapes.
• Continue to assist the Agency in
implementing food safety standards
under FSMA.
C. Eligibility Information
The University of California-Davis
(UC Davis), WCFS
Competition is limited to WCFS
because FDA has determined that WCFS
is uniquely qualified to fulfill the
objectives outlined in the proposed
cooperative agreement. The program has
demonstrated the adaptability necessary
to address FDA’s evolving high-priority
public health issues. This adaptability
allows WCFS to successfully leverage
resources across a variety of
organizations including the U.S.
Department of Agriculture—National
Institute of Food and Agriculture,
Center for Produce Safety, numerous
industry boards, and also with
universities across the country. This has
led to the expansion of the program and
has also increased their visibility as a
food safety resource thus propagating
additional collaborations. In addition,
the WCFS locations at the UC Davis
main campus and experimental stations
provide invaluable access to one of the
leading food production and food safety
research institutions in the country with
prominent researchers and access to
agricultural producers, along with other
public and private stakeholders. This
established UC Davis network allows
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
37229
WCFS to offer technical assistance that
will aid in the protection of public
health by increasing the adoption and
understanding of guidance and policy.
WCFS has conducted research on
diverse agriculture production issues of
importance to FDA including common
routes of contamination on a farm,
environmental contamination, and
agricultural practices and possesses the
ability to further expand their research
into other production areas. The
location of WCFS affords FDA the
opportunity to obtain data from
meaningful, field-based trials in an
important food-producing area of the
country. WCFS access to field sites for
experimental trials is instrumental to
FDA receiving the most current
scientifically validated information that
relates to actual agricultural conditions.
WCFS has established research
collaborations with research institutions
throughout the United States including
Florida, Arizona, Georgia, Ohio, and
Hawaii to study the agro-ecological
differences that may impact food safety
in the agricultural sector. WCFS has also
made available research tools that can
be utilized by all research institutions
that could facilitate industry
compliance with preventive control
standards. Information gleaned from
this research has been made publicly
available and has been useful to
domestic and international stakeholders
and often translates into proactive,
science-based preventive controls. FDA
has utilized this information when
developing policy aimed at fulfilling its
public health mission. Industry boards
and grower groups have also
incorporated WCFS generated
information into their national and
regional food safety guidance
documents.
WCFS has also effectively provided
extensive technical outreach and
education through participation on high
profile advisory boards/panels covering
diverse agricultural topics including but
not limited to good agricultural
practices, tree nuts, veterinary science,
and specialty crops that span the United
States. Additionally, WCFS regularly
outreaches to the agricultural
community through conferences and
meetings to provide information about
best practices. Finally, WCFS and FDA
have also provided opportunities for
postgraduates to be trained and
mentored by WCFS and FDA scientists
in areas of field, laboratory, and
educational research.
E:\FR\FM\20JNN1.SGM
20JNN1
37230
Federal Register / Vol. 78, No. 119 / Thursday, June 20, 2013 / Notices
II. Award Information/Funds Available
A. Award Amount
Food and Drug Administration
The Center for Food Safety and
Applied Nutrition at FDA intends to
fund one award up to $2 million for
FY13, with the possibility of four
additional years of support, subject to
the availability of funds. Future year
amounts will depend on annual
appropriations and successful
performance.
[Docket No. FDA–2007–D–0369]
Draft and Revised Draft Guidances for
Industry Describing Product-Specific
Bioequivalence Recommendations;
Availability
AGENCY:
ACTION:
The award will provide 1 year of
support, with the possibility of four
additional years of support, contingent
upon satisfactory performance in the
achievement of project and program
reporting objectives during the
preceding year and the availability of
Federal fiscal year appropriations.
III. Paper Application, Registration,
and Submission Information
To submit a paper application in
response to this FOA, applicants should
first review the full announcement
located at www.fda.gov/food/
newsevents/default.htm. (FDA has
verified the Web site addresses
throughout this document, but FDA is
not responsible for any subsequent
changes to the Web sites after this
document publishes in the Federal
Register.) Persons interested in applying
for a grant may obtain an application at
https://grants.nih.gov/grants/forms.htm.
For all paper application submissions,
the following steps are required:
TKELLEY on DSK3SPTVN1PROD with NOTICES
• Step 1: Obtain a Dun and Bradstreet
(DUNS) Number
• Step 2: Register With System for
Award Management (SAM)
• Step 3: Register With Electronic
Research Administration (eRA)
Commons
Steps 1 and 2, in detail, can be found
at https://www07.grants.gov/applicants/
organization_registration.jsp. Step 3, in
detail, can be found at https://
commons.era.nih.gov/commons/
registration/registrationInstructions.jsp.
After you have followed these steps,
submit paper applications to the Grants
Management Officer/Specialist listed
above.
Dated: June 14, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2013–14673 Filed 6–19–13; 8:45 am]
BILLING CODE 4160–01–P
17:01 Jun 19, 2013
Jkt 229001
Food and Drug Administration,
HHS.
B. Length of Support
VerDate Mar<15>2010
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Notice.
The Food and Drug
Administration (FDA) is announcing the
availability of additional draft and
revised draft product-specific
bioequivalence (BE) recommendations.
The recommendations provide productspecific guidance on the design of BE
studies to support abbreviated new drug
applications (ANDAs). In the Federal
Register of June 11, 2010, FDA
announced the availability of a guidance
for industry entitled ‘‘Bioequivalence
Recommendations for Specific
Products,’’ which explained the process
that would be used to make productspecific BE recommendations available
to the public on FDA’s Web site. The BE
recommendations identified in this
notice were developed using the process
described in that guidance.
DATES: Although you can comment on
any guidance at any time (see 21 CFR
10.115(g)(5)), to ensure that the Agency
considers your comments on these draft
and revised draft guidances before it
begins work on the final versions of the
guidances, submit either electronic or
written comments on the draft and
revised draft product-specific BE
recommendations listed in this notice
by August 19, 2013.
ADDRESSES: Submit written requests for
single copies of the individual BE
guidances to the Division of Drug
Information, Center for Drug Evaluation
and Research, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 51, Rm. 2201, Silver Spring,
MD 20993–0002. Send one selfaddressed adhesive label to assist that
office in processing your requests. See
the SUPPLEMENTARY INFORMATION section
for electronic access to the draft
guidance recommendations.
Submit electronic comments on the
draft product-specific BE
recommendations to https://
www.regulations.gov. Submit written
comments to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, Rm.
1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Kris
´
Andre, Center for Drug Evaluation and
SUMMARY:
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
Research (HFD–600), Food and Drug
Administration, 7519 Standish Pl.,
Rockville, MD 20855, 240–276–9326.
SUPPLEMENTARY INFORMATION:
I. Background
In the Federal Register of June 11,
2010 (75 FR 33311), FDA announced the
availability of a guidance for industry
entitled ‘‘Bioequivalence
Recommendations for Specific
Products,’’ which explained the process
that would be used to make productspecific BE recommendations available
to the public on FDA’s Web site at
https://www.fda.gov/Drugs/Guidance
ComplianceRegulatoryInformation/
Guidances/default.htm. As described in
that guidance, FDA adopted this process
as a means to develop and disseminate
product-specific BE recommendations
and provide a meaningful opportunity
for the public to consider and comment
on those recommendations. Under that
process, draft recommendations are
posted on FDA’s Web site and
announced periodically in the Federal
Register. The public is encouraged to
submit comments on those
recommendations within 60 days of
their announcement in the Federal
Register. FDA considers any comments
received and either publishes final
recommendations or publishes revised
draft recommendations for comment.
Recommendations were last announced
in the Federal Register of December 17,
2012 (77 FR 74669). This notice
announces draft product-specific
recommendations, either new or
revised, that are being posted on FDA’s
Web site concurrently with publication
of this notice.
II. Drug Products for Which New Draft
Product-Specific BE Recommendations
Are Available
FDA is announcing new draft
product-specific BE recommendations
for drug products containing the
following active ingredients:
A
Apixaban
Artemether; Lumefantrine
Asenapine maleate
B
Balsalazide disodium
C
Cycloserine
Cyclosporine
E
Eltrombopag olamine
F
Fluoxetine
H
Hydrochlorothiazide; Triamterene
M
Medroxyprogesterone (multiple reference
listed drugs)
Methyltestosterone
E:\FR\FM\20JNN1.SGM
20JNN1
]]>Agencies
[Federal Register Volume 78, Number 119 (Thursday, June 20, 2013)]
[Notices]
[Pages 37228-37230]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-14673]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2013-N-0010]
Cooperative Agreement To Support the Western Center for Food
Safety
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing the
availability of grant funds for a cooperative agreement to support the
Western Center for Food Safety (WCFS). FDA regards the continued
support of WCFS as crucial to receiving invaluable insight into the
food safety issues that it is directed to address through various
provisions of the FDA Food Safety Modernization Act (FSMA). FDA
concludes this partnership will enhance FDA's efforts to address the
particularly complex issues surrounding the safety of agricultural
production. Partnering with WCFS provides FDA with the opportunity to
stimulate collaborations so that resources can be leveraged to maximize
food safety research, education, and outreach efforts aimed at WCFS and
FDA stakeholders particularly those within the agricultural community.
A key outcome of this effort is to enhance FDA's implementation of the
prevention oriented activities outlined in FSMA.
DATES: Important dates are as follows:
1. The application due date is July 15, 2013.
2. The anticipated start date is September, 2013.
3. The opening date is June 20, 2013.
4. The expiration date is July 16, 2013.
ADDRESSES: Submit the paper application to: Gladys Melendez, Grants
Management (HFA-500), 5630 Fishers Lane, Rockville, MD 20857, and a
copy to Kevin W. Robinson, Center for Food Safety and Applied
Nutrition, 5100 Paint Branch Pkwy., College Park, MD 20740, 240-402-
2118. For more information, see section III of the SUPPLEMENTARY
INFORMATION section of this notice.
FOR FURTHER INFORMATION CONTACT: Samir K. Assar, Center for Food Safety
and Applied Nutrition, Food and Drug Administration, CPK1 Rm. 3A001,
5100 Paint Branch Pkwy., College Park, MD 20740, 240-402-1636; or
Gladys Melendez, Grants Management Officer/Specialist, Office of
Acquisition and Grants Services, Food and Drug Administration, 5630
Fishers Lane, Rm. 2032, Rockville, MD 20857, 301-827-7175.
For more information on this funding opportunity announcement (FOA)
and to obtain detailed requirements, please refer to the full FOA
located at www.fda.gov/food/newsevents/default.htm.
SUPPLEMENTARY INFORMATION:
I. Funding Opportunity Description
RFA-FD-13-023.
93.103.
A. Background
FDA is announcing its intention to receive and consider a single-
source application for the award of a cooperative agreement in fiscal
year 2013 (FY13) to the University of California-Davis, Davis, CA, to
support WCFS.
[[Page 37229]]
The partnership between WCFS and FDA over the past 5 years has been
very productive in supporting FDA's public health mission by conducting
studies that address knowledge gaps surrounding the safe production of
agricultural foods and education/outreach activities that provide the
agricultural sector with information about food safety best practices.
With the enactment of FSMA in 2011, the partnership has become
increasingly important as FDA works to fulfill its mandate to develop a
prevention-based modern food safety system. FSMA directs the Agency to
develop and implement risk and science-based enforceable standards and
enhance partnerships with its food safety stakeholders. The Agency's
research strategy is focused on building the scientific foundation it
needs to support the development and implementation of science-based
standards. The strategy involves identifying and prioritizing its
research needs based on its policymaking and implementation activities.
WCFS has played a critical role in conducting studies that were used to
inform policy, including regulations that are being developed under
FSMA, and will continue to do so as the Agency further implements FSMA
activities.
FDA regards the development and strengthening of public-private
partnerships to be a key element of its FSMA implementation strategy,
which involves providing education and outreach to private industry
about its food safety standards in order to build industry capacity to
comply with these standards prior to conducting enforcement activities.
The Agency has a limited history with the agricultural community and
seeks to use the strong relationships that academia has with this
sector to facilitate education and outreach activities. The
demonstrated ability of WCFS to successfully leverage resources through
existing partnerships will continue to maximize the ability to achieve
research, education, and outreach objectives domestically and
internationally with available funds. The Agency is developing a
technical assistance network that will be critical in providing
technical assistance to the farming community in adopting and complying
with components of FSMA. WCFS is optimally situated to be a key player
in this network to deliver quality technical assistance to a broad
range of food safety stakeholders in the agricultural community.
B. Research Objectives
This cooperative agreement will provide continued support so that
WCFS can meet the following research objectives:
Continue to conduct multidisciplinary applied laboratory,
field, and educational research regarding the safety of agriculture
production to generate practical solutions that can be implemented by
the agricultural community and consequently, enhance food safety and
food defense for FDA-regulated products.
Continue to develop and maintain communication with
various stakeholders, domestic and international, involved in food
production and food safety in order to identify food safety knowledge
gaps and opportunities to leverage resources.
Continue to enhance technical assistance outreach and
educational efforts through various channels, including seminars,
presentations, serving on technical advisory boards and committees, and
outreach through agriculture extension appointments.
Continue to engage in multi-institutional collaborations
to ensure that FDA has the most current scientific thinking on best
agricultural practices across varying agro-ecological landscapes.
Continue to assist the Agency in implementing food safety
standards under FSMA.
C. Eligibility Information
The University of California-Davis (UC Davis), WCFS
Competition is limited to WCFS because FDA has determined that WCFS
is uniquely qualified to fulfill the objectives outlined in the
proposed cooperative agreement. The program has demonstrated the
adaptability necessary to address FDA's evolving high-priority public
health issues. This adaptability allows WCFS to successfully leverage
resources across a variety of organizations including the U.S.
Department of Agriculture--National Institute of Food and Agriculture,
Center for Produce Safety, numerous industry boards, and also with
universities across the country. This has led to the expansion of the
program and has also increased their visibility as a food safety
resource thus propagating additional collaborations. In addition, the
WCFS locations at the UC Davis main campus and experimental stations
provide invaluable access to one of the leading food production and
food safety research institutions in the country with prominent
researchers and access to agricultural producers, along with other
public and private stakeholders. This established UC Davis network
allows WCFS to offer technical assistance that will aid in the
protection of public health by increasing the adoption and
understanding of guidance and policy.
WCFS has conducted research on diverse agriculture production
issues of importance to FDA including common routes of contamination on
a farm, environmental contamination, and agricultural practices and
possesses the ability to further expand their research into other
production areas. The location of WCFS affords FDA the opportunity to
obtain data from meaningful, field-based trials in an important food-
producing area of the country. WCFS access to field sites for
experimental trials is instrumental to FDA receiving the most current
scientifically validated information that relates to actual
agricultural conditions. WCFS has established research collaborations
with research institutions throughout the United States including
Florida, Arizona, Georgia, Ohio, and Hawaii to study the agro-
ecological differences that may impact food safety in the agricultural
sector. WCFS has also made available research tools that can be
utilized by all research institutions that could facilitate industry
compliance with preventive control standards. Information gleaned from
this research has been made publicly available and has been useful to
domestic and international stakeholders and often translates into
proactive, science-based preventive controls. FDA has utilized this
information when developing policy aimed at fulfilling its public
health mission. Industry boards and grower groups have also
incorporated WCFS generated information into their national and
regional food safety guidance documents.
WCFS has also effectively provided extensive technical outreach and
education through participation on high profile advisory boards/panels
covering diverse agricultural topics including but not limited to good
agricultural practices, tree nuts, veterinary science, and specialty
crops that span the United States. Additionally, WCFS regularly
outreaches to the agricultural community through conferences and
meetings to provide information about best practices. Finally, WCFS and
FDA have also provided opportunities for postgraduates to be trained
and mentored by WCFS and FDA scientists in areas of field, laboratory,
and educational research.
[[Page 37230]]
II. Award Information/Funds Available
A. Award Amount
The Center for Food Safety and Applied Nutrition at FDA intends to
fund one award up to $2 million for FY13, with the possibility of four
additional years of support, subject to the availability of funds.
Future year amounts will depend on annual appropriations and successful
performance.
B. Length of Support
The award will provide 1 year of support, with the possibility of
four additional years of support, contingent upon satisfactory
performance in the achievement of project and program reporting
objectives during the preceding year and the availability of Federal
fiscal year appropriations.
III. Paper Application, Registration, and Submission Information
To submit a paper application in response to this FOA, applicants
should first review the full announcement located at www.fda.gov/food/newsevents/default.htm. (FDA has verified the Web site addresses
throughout this document, but FDA is not responsible for any subsequent
changes to the Web sites after this document publishes in the Federal
Register.) Persons interested in applying for a grant may obtain an
application at https://grants.nih.gov/grants/forms.htm. For all paper
application submissions, the following steps are required:
Step 1: Obtain a Dun and Bradstreet (DUNS) Number
Step 2: Register With System for Award Management (SAM)
Step 3: Register With Electronic Research Administration (eRA)
Commons
Steps 1 and 2, in detail, can be found at https://www07.grants.gov/applicants/organization_registration.jsp. Step 3, in detail, can be
found at https://commons.era.nih.gov/commons/registration/registrationInstructions.jsp. After you have followed these steps,
submit paper applications to the Grants Management Officer/Specialist
listed above.
Dated: June 14, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2013-14673 Filed 6-19-13; 8:45 am]
BILLING CODE 4160-01-P
